Answers are grounded in this paper and cite their sources.
Summary: Sotillo and colleagues describe the molecular events associated with apparent loss of target antigen expression following CAR T-cell therapy. We propose that broader immune activation is required to prevent outgrowth of tumor antigen escape variants following targeted therapies. Cancer Discov; 5(12); 1238–40.
No takes yet. Share an insight, caveat, or question.
Jackson et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: